Device for transiently contacting at least one unit for capturing biological targets with a fluid containing them, method for recovering the captured targets and system for contacting and recovery

• US 9,642,602 B2
• Filed: 01/10/2011
• Issued: 05/09/2017
• Est. Priority Date: 01/14/2010
• Status: Expired due to Fees

• Current Assignee: Commissariat a L'Energie Atomique (AES Corporation), Institut National De La Sante Et De La Recherche Medicale (Inserm) (Allianz Global Investors GmbH), Centre Hospitalier Universitaire de Grenoble, Universite Joseph Fourier
• Original Assignee: Commissariat a L'Energie Atomique (AES Corporation), Institut National De La Sante Et De La Recherche Medicale (Inserm) (Allianz Global Investors GmbH), Centre Hospitalier Universitaire de Grenoble, Universite Joseph Fourier
• Inventors: Caillat, Patrice, Berger, Franois, Campagnolo, Raymond, Cosnier, Marie-Line, Zaccaria, Affif
• Primary Examiner(s): Stout, Michael C
• Application Number:
  US13/521,632
• Publication Number:
  US 20130079663A1
• Time in Patent Office: 2,311 Days
• CPC Class Codes: A61B 10/0045 Devices for taking samples of body liquids devices for taking blood samples A61B5/15
• CPC Class Codes: A61B 10/02 Instruments for taking cell samples or for biopsy A61B10/0038 and A61B10/0045 take precedence; needle locating or guiding means A61B17/3403; samplers for enzymology or microbiology C12M1/26; sampling or preparing biological specimens G01N33/48
• CPC Class Codes: A61B 2010/008 Interstitial fluid

Abstract

The invention relates to a device for transiently contacting at least one unit for capturing biological targets with a body fluid containing them, a method for recovering the captured targets for analysis, and a system for contacting and recovering a capture substrate included in said unit. The invention relates to samples obtained in particular in vivo from body fluids of the human body, e.g. circulating body fluids, said fluids possibly containing, as targets, proteins, oligonucleotides such as RNA or DNA, antibodies, enzymes or cells. A contacting device (1) according to the invention comprises: —a sampling tip (2) having a contacting end intended to be introduced into a medium containing said fluid, and—the or each capturing unit which is bound to said end and which comprises a capture substrate (3) defining a target capturing surface covered with at least one biocompatible and porous crosslinked polymer layer (4) designed to retain the or each capture substrate and only to allow biological particles including targets smaller than a limiting size to pass through, in such a way that the or each capture substrate is recoverable after said contacting by dissolution of the or each layer.

Claims

1. A device for transient contacting notably in vivo of an one unit for capturing biological targets with a body fluid containing said targets, said device comprising:

a sampling tip having a contacting end configured to be introduced into a medium containing said fluid, and

said capturing unit, which is bound to said contacting end and which comprises a capture substrate defining a target capturing surface covered with a biocompatible and porous crosslinked polymer layer configured to retain said capture substrate and only to allow biological particles including said targets smaller than a limiting size to pass through, in such a way that said capture substrate is recoverable after this contacting by dissolution of said polymer layer;

wherein said capturing unit is connected to said contacting end of the tip via connecting means, which are fixed to said contacting end by welding or gluing, and said connecting means comprise a biocompatible porous bag which is fixed to said contacting end of the tip and which envelops said capturing unit, which contains particles that constitute said substrate and that are embedded in said polymer layer.

2. The device according to claim 1, wherein said capturing surface of said capture substrate is constituted of a part of the surface of the tip and/or is connected to said tip, said surface being functionalized by grafted functional groups which are designed to interact with said targets in order to capture them, these functional groups being selected from the group consisting of anionic functions, cationic functions, antibodies and oligonucleotides.

3. The device according to claim 1, wherein said polymer layer has a porosity defining said limiting size which is between 30 nm and 500 nm.

4. The device according to claim 1, wherein said or each polymer layer covers a defined zone of the wall of the tip, which is of the needle or catheter type.

5. The device according to claim 4, wherein said capturing surface of said capture substrate defines at least one functionalized surface of the tip which is defined:

by said defined zone of the tip before it is covered by said polymer layer, and/or

by the respective functionalized surfaces of particles embedded in said polymer layer.

6. The device according to claim 4, wherein said capturing surface of said capture substrate is constituted exclusively or partly of said functional groups that are formed on the surface directly on said defined zone of the functionalized wall of the tip and covered with said polymer layer.

7. The device according to claim 5, wherein said capture substrate is constituted exclusively or partly of said surface-functionalized particles which are embedded in said polymer layer, these particles being of the magnetic or non-magnetic type and being nanobeads or nanospheres made of a ferromagnetic material with an average size between 50 nm and 250 nm.

8. The device according to claim 4, wherein said defined zone of the wall of the tip forms a dish, a groove or a slit, so as to facilitate adhesion of said polymer layer directly on said defined zone of the tip.

9. The device according to claim 1, wherein said porous bag envelops a plurality of said capturing units of approximately spherical shape, each capturing unit of said comprising a capture substrate in the form of particles, which are of the magnetic or non-magnetic type and are nanobeads or nanospheres made of a ferromagnetic material, said particles having an average size between 50 nm and 250 nm.

10. The device according to claim 1, wherein said polymer layer is based on at least one biocompatible polymer with reversible gelation selected from the group consisting of alginate gels, copolymers of alginate and of poly-L-lysine, chitosan, agarose, cellulose, poly(trimethylammonium ethylacrylate methyl sulphate)-b-poly(acrylamide), poly(hydroxyethylmethacrylate) (HEMA), poly(hydroxyethylmethacrylate-methyl ethacrylate) (HEMA-MMA) and other copolymers based on methacrylate, polyethylene glycols, copolymers of acrylonitrile and of polyethylene glycol, polysaccharides and mixtures thereof.

11. The device according to claim 10, wherein said polymer layer is based on at least one alginate gel, which is gelled by means of polycations selected from the group consisting of polycations of calcium, barium, iron and strontium.

12. System for transient contacting of at least one unit for capturing biological targets with a body fluid containing these targets, and for recovering a capture substrate included in the or each capturing unit, wherein this system comprises a device for transient contacting according to claim 1 and further comprises:

means for dissolving said polymer layer after said contacting, to provide access to said capture substrate that is embedded therein and that is bound or is not bound to said targets to be analysed, said dissolving means comprising at least one chelating agent of said polycations, which is for sodium polycations, ethylenediamine tetraacetic acid (EDTA) or sodium citrate, and

means for recovery of said or each capture substrate, in the case when said substrate is constituted of magnetic particles with respective functionalized surfaces.

13. Method for recovery of biological targets previously captured by a contacting the device according to claim 1, notably by grafting of said targets onto the capturing surface of said capturing unit, wherein the method comprises the following successive stages:

washing of the capturing unit bound to said contacting end of the tip with a buffer solution,

dissolution of said polymer layer covering said or each capture substrate, then

analysis of the biological targets present on the capturing surface of said or each capture substrate.

14. The method of claim 13, wherein said dissolution is performed by at least one chelating agent of polycations.